1. Khairallah P, Aggarwal N, Awan AA, et al. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient-one year into the pandemic. Transplant Int. 2021;34(4):612-621. doi:10.1111/tri. 13794
2. Özer MR, Avcı A, Baloğlu İ, Zeybek Aydın K. Factors associated with intensive care hospitalization in patients with COVID-19. Selcuk Med J. 2022;38(2):1-6. doi:10.30733/smj.2022.38.2.1
3. Galván NTN, Moreno NF, Garza JE, et al. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant. 2020;20(11):3113-3122. doi:10. 1111/ajt.16104
4. Boyarsky BJ, Werbel WA, Durand CM, et al. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020;20(11):3131-3139. doi:10. 1111/ajt.16167
5. Süleymanlar G, Utaş C, Arınsoy T, et al. A population-based survey of chronic renal disease in Turkiye-the CREDIT study. Nephrol Dial Transplant. 2011;26(6):1862-1871. doi:10.1093/ndt/gfq746
6. Hall RK, Luciano A, Pieper C, Colón-Emeric CS. Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis. BMC Nephrol. 2018;19:1-9. doi: 10.1186/s12882-018-0903-7
7. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662-1673. doi:10.1016/S0140-6736(12)61350-6
8. Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F. The cardiovascular burden in end-stage renal disease. Expanded Hemodialysis. 2017;191:44-57. doi:10.1016/j.exhe.2017.02.001
9. Mohan S, King KL, Husain SA, Schold JD. COVID-19-associated mortality among kidney transplant recipients and candidates in the United States. Clin J Am Soc Nephrol. 2021;16(11):1695-1703. doi:10.2215/CJN.02690221
10. Craig-Schapiro R, Salinas T, Lubetzky M, et al. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am J Transplant. 2021;21(4):1576-1585. doi:10.1111/ajt.16351
11. Shivanna S, Kolandaivelu K, Shashar M, et al. The aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia. J Am Soc Nephrol. 2016;27(1):189-200. doi:10.1681/ASN.2015050577
12. Liakopoulos V, Roumeliotis S, Gorny X, Eleftheriadis T, Mertens PR. Oxidative stress in patients undergoing peritoneal dialysis: a current review of the literature. Oxid Med Cell Longev. 2017;2017:1-9. doi:10. 1155/2017/7102193
13. Cifci A, Inal S, Kaya C. Asymmetric dimethyl arginine levels in chronic hemodialysis patients. Turk J Med Sci. 2014;44(4):606-610. doi:10.3906/sag-1305-31
14. Emrich IE, Zawada AM, Martens-Lobenhoffer J, et al. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Clin Res Cardiol. 2018;107:201-213. doi:10.1007/s00392-017-1183-3
15. Vervloet MG, Sezer S, Massy ZA, et al. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13(1):27-38. doi:10.1038/nrneph.2016.161
16. Wang Z, Jiang A, Wei F, Chen H. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):1-8. doi:10.1186/s12872-018-0853-1
17. Nesrallah GE, Mustafa RA, MacRae J, et al. Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis. Am J Kidney Dis. 2013;62(1):187-198. doi:10.1053/j.ajkd.2013.02.373
18. Surdacki A, Wieczorek-Surdacka E, Sulowicz W, Dubiel J. Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant. 1995;10(7):1218-1223. doi:10.1093/ndt/10.7.1218
19. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270(11):1339-1343. doi:10.1001/jama. 1993.03510110039030
20. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730. doi:10.1056/NEJM199912023412301
21. Schnuelle P, Lorenz D, Trede M, Van Der Woude F. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998;9(11):2135-2141. doi:10. 1681/ASN.V9112135
22. Ateş K, Koçyiğit İ. Türkiye’de Nefroloji, Diyaliz ve Transplantasyon - Registry 2022. BAYT Bilimsel Araştırma Basım ve Yayın; 2023.
</ol>
<p>